Maxigen Biotech Inc. (1783.TW)

TWD 46.3

(-0.43%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.49 Billion 1.44 Billion 1.26 Billion 956.47 Million 1.18 Billion 1.13 Billion
Total Current Assets 619.56 Million 993.24 Million 783.55 Million 432.05 Million 640.15 Million 599.52 Million
Cash And Short Term Investments 432.58 Million 801.26 Million 540.17 Million 222.89 Million 432.69 Million 417.09 Million
Cash and Cash Equivalents 431.08 Million 790.94 Million 513.3 Million 209.76 Million 267.64 Million 184.84 Million
Short Term Investments 1.5 Million 10.31 Million 26.87 Million 13.13 Million 165.04 Million 232.25 Million
Net Receivables 101.71 Million 115.82 Million 164.16 Million 100.25 Million 106.21 Million 86.55 Million
Inventory 85.18 Million 75.27 Million 78.95 Million 86.98 Million 88.11 Million 82.61 Million
Other Current Assets 77 Thousand 889 Thousand 256 Thousand 21.91 Million 13.12 Million 13.25 Million
Total Non-Current Assets 873.42 Million 454.47 Million 481.63 Million 524.41 Million 545.33 Million 535.93 Million
Net PPE 424.17 Million 434.62 Million 465.45 Million 481.51 Million 502.09 Million 494.02 Million
Good Will And Intangible Assets 486 Thousand 1.16 Million 1.83 Million 1.67 Million 2.23 Million 2.58 Million
Good Will - - - - - -
Intangible Assets 486 Thousand 1.16 Million 1.83 Million 1.67 Million 2.23 Million 2.58 Million
Long-Term Investments 431.3 Million 8.82 Million 8.85 Million 12.26 Million 12.44 Million 12.51 Million
Tax Assets 5.83 Million 3.19 Million 378 Thousand 1.06 Million 2.06 Million 1.19 Million
Other Non Current Assets 11.62 Million 6.67 Million 5.11 Million 27.89 Million 26.5 Million 25.6 Million
Other Assets - - - - - -
Total Liabilities 131.88 Million 152.06 Million 123.46 Million 96.24 Million 334.16 Million 292.47 Million
Total Current Liabilities 131.37 Million 151.5 Million 116.06 Million 86.58 Million 321.95 Million 292.38 Million
Account Payables 17.11 Million 35.93 Million 40.05 Million 33 Million 33.96 Million 30.99 Million
Tax Payables 24.46 Million 27.16 Million 9.28 Million 8.69 Million 13.07 Million 381 Thousand
Short Term Debt 50 Thousand - 2.46 Million 2.49 Million 2.56 Million 213.23 Million
Deferred Revenue 113.43 Million - 73.53 Million 47.27 Million 61.85 Million -213.23 Million
Other Current Liabilities 773 Thousand 115.56 Million 22 Thousand 3.81 Million 223.56 Million 261.39 Million
Total Non Current Liabilities 510 Thousand 566 Thousand 7.39 Million 9.65 Million 12.21 Million 89 Thousand
Long-Term Debt - - 7.27 Million 9.64 Million 12.13 Million -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 19 Thousand 19 Thousand 120 Thousand 19 Thousand 89 Thousand 89 Thousand
Other Liabilities - - - - - -
Total Equity 1.36 Billion 1.29 Billion 1.14 Billion 860.22 Million 851.31 Million 842.97 Million
Stock Holders Equity 1.36 Billion 1.29 Billion 1.14 Billion 860.22 Million 851.31 Million 842.97 Million
Common Stock 890.29 Million 846.99 Million 769.99 Million 694.65 Million 694.65 Million 708.47 Million
Retained Earnings 199.44 Million 138.51 Million 87.7 Million 63.16 Million 60.05 Million 57.52 Million
Accumulated other comprehensive income 272.31 Million 310.14 Million 284.02 Million 21.69 Million 15.89 Million 10.08 Million
Common Stock Equity 1.36 Billion 1.29 Billion 1.14 Billion 860.22 Million 851.31 Million 842.97 Million
Capital Lease Obligation - - 9.64 Million 12.13 Million 14.69 Million -
Total Investments 432.8 Million 10.31 Million 26.87 Million 13.13 Million 165.04 Million 232.25 Million
Total Debt 50 Thousand - 9.74 Million 12.13 Million 14.69 Million 213.23 Million
Net Debt -431.03 Million -790.94 Million -503.56 Million -197.62 Million -252.95 Million 28.38 Million

Balance Sheet Charts